MoneyWorks4Me

RPG Life Sciences - Quaterly Results

19 Jul 2024 Evaluate
The Revenue for the quarter ended  June 2024 of Rs. 1654.20 millions grew by 11.94 % from Rs. 1477.80 millions.Profit saw a slight increase of 21.09%to Rs. 267.60  millions from Rs. 221.00 millions.OP of the company witnessed a marginal growth to 414.40 millions from 340.50 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1654.20 1477.80 11.94 1654.20 1477.80 11.94 5820.50 5128.10 13.50
Other Income 23.70 18.10 30.94 23.70 18.10 30.94 72.10 48.00 50.21
PBIDT 414.40 340.50 21.70 414.40 340.50 21.70 1353.60 1074.90 25.93
Interest 1.50 0.70 114.29 1.50 0.70 114.29 4.50 3.10 45.16
PBDT 412.90 339.80 21.51 412.90 339.80 21.51 1349.10 1071.80 25.87
Depreciation 52.90 42.10 25.65 52.90 42.10 25.65 170.70 155.00 10.13
PBT 360.00 297.70 20.93 360.00 297.70 20.93 1178.40 916.80 28.53
TAX 92.40 76.70 20.47 92.40 76.70 20.47 301.80 240.40 25.54
Deferred Tax -2.70 -2.50 8.00 -2.70 -2.50 8.00 -23.60 -3.10 661.29
PAT 267.60 221.00 21.09 267.60 221.00 21.09 876.60 676.40 29.60
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 25.05 23.04 8.73 25.05 23.04 8.73 23.26 20.96 10.95
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..